Menu
Back to Archived Journals » Gastrointestinal Cancer: Targets and Therapy » Volume 4 » default
Gastrointestinal Cancer: Targets and Therapy ceased publishing in December 2018. All articles that have been published in Gastrointestinal Cancer: Targets and Therapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Gastrointestinal Cancer: Targets and Therapy
ISSN: 1179-9919
- View all (55)
- Volume 8, 2018 (3)
- Volume 7, 2017 (5)
- Volume 6, 2016 (6)
- Volume 5, 2015 (12)
- Volume 4, 2014 (12)
- Volume 3, 2013 (4)
- Volume 2, 2012 (5)
- Volume 1, 2011 (8)
Archive: Volume 4, 2014
Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy
Baird A, Lee J, Podvin S, Kurabi A, Dang X, Coimbra R, Costantini T, Bansal V, Eliceiri BP
Gastrointestinal Cancer: Targets and Therapy 2014, 4:131-142
Published Date: 24 October 2014
Targeting cancer stem cells in gastric cancer
Ishimoto T, Baba H
Gastrointestinal Cancer: Targets and Therapy 2014, 4:123-129
Published Date: 15 October 2014
STAT3 as an emerging molecular target in pancreatic cancer
Sharma NK, Shankar S, Srivastava RK
Gastrointestinal Cancer: Targets and Therapy 2014, 4:115-122
Published Date: 25 August 2014
Association between time to disease progression end points and overall survival in patients with neuroendocrine tumors
Singh S, Wang X, Law CHL
Gastrointestinal Cancer: Targets and Therapy 2014, 4:103-113
Published Date: 16 August 2014
Emerging treatments for advanced pancreatic cancer: clinical potential of albumin-bound paclitaxel
Fontana E, Sclafani F, Cunningham D
Gastrointestinal Cancer: Targets and Therapy 2014, 4:89-101
Published Date: 25 June 2014
Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer
Azevedo-Pouly ACP, Schmittgen TD
Gastrointestinal Cancer: Targets and Therapy 2014, 4:75-87
Published Date: 18 June 2014
Critical analysis of the potential for the therapeutic targeting of the Sp1 transcription factor in pancreatic cancer
Jutooru I, Chadalapaka G, Safe S
Gastrointestinal Cancer: Targets and Therapy 2014, 4:65-74
Published Date: 17 June 2014
WNT/β-catenin pathway activation in hepatocellular carcinoma: a clinical perspective
Ma L, Wei W, Chua M-S, So S
Gastrointestinal Cancer: Targets and Therapy 2014, 4:49-63
Published Date: 10 April 2014
Critical analysis of the potential for therapeutic targeting of mammalian target of rapamycin (mTOR) in gastric cancer
Inokuchi M, Kato K, Kojima K, Sugihara K
Gastrointestinal Cancer: Targets and Therapy 2014, 4:39-48
Published Date: 8 April 2014
Assessing the role of the EGF receptor in the development and progression of pancreatic cancer
Cook N, Frese KK, Moore M
Gastrointestinal Cancer: Targets and Therapy 2014, 4:23-37
Published Date: 2 April 2014
Targeting HER2 amplifications in gastric cancer
Ung L, Chua TC, Merrett ND
Gastrointestinal Cancer: Targets and Therapy 2014, 4:11-22
Published Date: 31 January 2014
New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team
Boichuk S, Rausch JL, Duensing A
Gastrointestinal Cancer: Targets and Therapy 2014, 4:1-10
Published Date: 12 December 2013